Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Next Generation Sequencing (NGS) Market: By Component: NGS Platforms, NGS services; By Technology: Sequencing By Synthesis, Ion Semiconductor Sequencing, Others; By Application; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Next Generation Sequencing (NGS) Market Outlook
The global next generation sequencing (NGS) market is projected to expand from USD 8 billion in 2020 to USD 24 billion by 2026 at a CAGR of 21% over the forecast period of 2021-2026.
-market.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Continuous technological innovation in sequencing technology has resulted in the development of reliable, powerful, low footprint, portable, and easy-to-use NGS platforms, which is aiding the growth of the global next generation sequencing (NGS) industry. Significant research and development have allowed systems to produce faster and more exact output and have raised product applications.
Properties and Applications
Next-generation sequencing is a new method of high-speed and low-cost genome sequencing. It is also known as the sequencing of the second generation or sequencing of large parallels. The global next generation sequencing (NGS) market can be divided based on segments like component, technology, and application.
-market-by-component.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be broadly categorised based on its component into:
- NGS Platforms
- NGS Services
The industry can be divided based on its technology as:
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time Sequencing
- Nanopore Sequencing
- Other
The industry can be divided on the basis of its application as:
- Diagnostics
- Drug Discovery
- Agricultural and Animal Research
- Others
The EMR report looks into the regional next generation sequencing markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
-market-by-region.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The advancements in systems for next-generation sequencing is driving the market growth. Technological advancements provide players with an immediate competitive edge, thus, ensuring consistent focus on product development and research. Developing advanced platforms provide players with a competitive edge, which aids the industry growth. Main players, as well as new players, are focusing on the continuous development to provide innovative sequencing technologies at a competitive price for various applications, which is expected to drive the industry over the forecast period.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global next generation sequencing market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Illumina, Inc. (NASDAQ: ILMN )
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies, Inc.
- PierianDx
- Genomatix GmbH
- Eurofins GATC Biotech GmbH
- Oxford Nanopore Technologies
- Macrogen, Inc.
- Thermo Fisher Scientific, Inc.
- DNASTAR, Inc.
- Biomatters Ltd.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Component, Technology, Application, Region |
| Breakup by Component | NGS Platforms, NGS Services |
| Breakup by Technology | Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other |
| Breakup by Application | Diagnostics, Drug Discovery, Agricultural & Animal Research, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Illumina, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Oxford Nanopore Technologies Limited, Macrogen, Inc., Thermo Fisher Scientific Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Next Generation Sequencing (NGS) Market Analysis
8.1 Key Industry Highlights
8.2 Global Next Generation Sequencing (NGS) Historical Market (2016-2020)
8.3 Global Next Generation Sequencing (NGS) Market Forecast (2021-2026)
8.4 Global Next Generation Sequencing (NGS) Market by Component
8.4.1 NGS Platforms
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 NGS Services
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.5 Global Next Generation Sequencing (NGS) Market by Technology
8.5.1 Sequencing by Synthesis
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Ion Semiconductor Sequencing
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.3 Single-Molecule Real-Time Sequencing
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2016-2020)
8.5.3.3 Forecast Trend (2021-2026)
8.5.4 Nanopore Sequencing
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2016-2020)
8.5.4.3 Forecast Trend (2021-2026)
8.5.5 Others
8.6 Global Next Generation Sequencing (NGS) Market by Application
8.6.1 Diagnostics
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Drug Discovery
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Agriculture & Animal Research
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Others
8.7 Global Next Generation Sequencing (NGS) Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Illumina, Inc.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 F. Hoffmann-La Roche Ltd.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Agilent Technologies, Inc.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Oxford Nanopore Technologies Limited
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Macrogen, Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Thermo Fisher Scientific Inc.
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 Others
12 Industry Events and Developments
List of Figures and Tables
1. Global Next Generation Sequencing (NGS) Market: Key Industry Highlights, 2016 and 2026
2. Global Next Generation Sequencing (NGS) Historical Market: Breakup by Component (USD Million), 2016-2020
3. Global Next Generation Sequencing (NGS) Market Forecast: Breakup by Component (USD Million), 2021-2026
4. Global Next Generation Sequencing (NGS) Historical Market: Breakup by Technology (USD Million), 2016-2020
5. Global Next Generation Sequencing (NGS) Market Forecast: Breakup by Technology (USD Million), 2021-2026
6. Global Next Generation Sequencing (NGS) Historical Market: Breakup by Application (USD Million), 2016-2020
7. Global Next Generation Sequencing (NGS) Market Forecast: Breakup by Application (USD Million), 2021-2026
8. Global Next Generation Sequencing (NGS) Historical Market: Breakup by Region (USD Million), 2016-2020
9. Global Next Generation Sequencing (NGS) Market Forecast: Breakup by Region (USD Million), 2021-2026
10. North America Next Generation Sequencing (NGS) Historical Market: Breakup by Country (USD Million), 2016-2020
11. North America Next Generation Sequencing (NGS) Market Forecast: Breakup by Country (USD Million), 2021-2026
12. Europe Next Generation Sequencing (NGS) Historical Market: Breakup by Country (USD Million), 2016-2020
13. Europe Next Generation Sequencing (NGS) Market Forecast: Breakup by Country (USD Million), 2021-2026
14. Asia Pacific Next Generation Sequencing (NGS) Historical Market: Breakup by Country (USD Million), 2016-2020
15. Asia Pacific Next Generation Sequencing (NGS) Market Forecast: Breakup by Country (USD Million), 2021-2026
16. Latin America Next Generation Sequencing (NGS) Historical Market: Breakup by Country (USD Million), 2016-2020
17. Latin America Next Generation Sequencing (NGS) Market Forecast: Breakup by Country (USD Million), 2021-2026
18. Middle East and Africa Next Generation Sequencing (NGS) Historical Market: Breakup by Country (USD Million), 2016-2020
19. Middle East and Africa Next Generation Sequencing (NGS) Market Forecast: Breakup by Country (USD Million), 2021-2026
20. Global Next Generation Sequencing (NGS) Market Structure
Key Questions Answered in the Report
In 2020, the global next generation sequencing (NGS) market attained a value of nearly USD 8 billion.
The market is projected to grow at a CAGR of 21% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach USD 24 billion by 2026.
The major drivers of the market include rising industrialisation, technological innovation, and advancements.
Growing emphasis on research and development by key players is the key industry trend propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
NGS platforms and NGS services are the component types of next generation sequencing (NGS).
The technological segments are sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing, among others.
The diverse applications for market are diagnostics, drug discovery, and agricultural and animal research, among others.
The major players in the industry are Illumina, Inc. (NASDAQ: ILMN), F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., PierianDx, Genomatix GmbH, Eurofins GATC Biotech GmbH, Oxford Nanopore Technologies, Macrogen, Inc., Thermo Fisher Scientific, Inc., DNASTAR, Inc., and Biomatters Ltd., among others.
Analyst Review
The global next generation sequencing (NGS) market attained a value of USD 8 billion in 2020, driven by the rising innovations in service. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 21%. The market is projected to reach USD 24 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its component types, the next generation sequencing (NGS) industry can be segmented into NGS platforms and NGS services. The classification based on technology are sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing, among others. On the basis of applications, the industry is divided into diagnostics, drug discover, and agricultural and animal research, among others. The major regional markets for next generation sequencing (NGS) are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include llumina, Inc. (NASDAQ: ILMN), F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., PierianDx, Genomatix GmbH, Eurofins GATC Biotech GmbH, Oxford Nanopore Technologies, Macrogen, Inc., Thermo Fisher Scientific, Inc., DNASTAR, Inc., and Biomatters Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global cell counting market attained a value of USD 10 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 7% to reach a value of USD 15.2 bill...
The global cancer screening market is driven by the surging cancer rates around the globe. Aided by the growing technological advancements, the market is expected to witness a further growth in the fo...
The global testosterone test kits market is being driven by the rising healthcare infrastructure and growing endocrine testing market. Aided by the growing R&D activities, the endocrine testing market...
The global glycated haemoglobin testing market witnessed a healthy growth in the historical period of 2016-2020 aided by rising prevalence of diabetes. The market is expected to grow at a CAGR of 9% d...
The global lipase testing market is being driven by the growing patient pool and lipase market. Aided by the rising research activities, the lipase market is expected to witness a healthy growth in th...
NEWSLETTER